For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Jikui Sun

USPTO Granted Patents = 10 (Patent Applications = 10)

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 17)

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

Shandong Danhong Pharmaceutical Co., Ltd.

D3 Bio (wuxi) Co., Ltd.

Cspc Zhongqi Pharmaceuticall Technology (shijiazhuang) Co., Ltd.

Simcere Pharmaceutical Co., Ltd.

Shandong Luye Pharmaceutical Co., Ltd.

Cisen Pharmaceutical Co., Ltd.

Cspc Zhongqi Pharmaceutical Technology (shijiazhuang) Co., Ltd.

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

Loading Chart...

Loading Chart...

10 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12410196 - Benzopyrimidine compounds and use thereof (2025-09-09),

2. 12398138 - FGFR inhibitor compound in solid form and preparation method therefor (2025-08-26),

3. 12162880 - Pyrimidoheterocyclic compounds and application thereof (2024-12-10),

4. 12012404 - Pyrimidoheterocyclic compounds and application thereof (2024-06-18),

5. 11464780 - Pyrazolopyrimidine derivative and use thereof (2022-10-11),

6. 11236094 - Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors (2022-02-01),

7. 11124523 - 2,6-dioxaspiro [4,5] decane derivatives and preparation method therefor and pharmaceutical applications thereof (2021-09-21),

8. 10030029 - Imidazole derivative used as antiviral agent and use thereof in preparation of medicament (2018-07-24),

9. 9868737 - Pyridino[1,2-A]pyrimidone analogue used as MTOR/P13K inhibitor (2018-01-16),

10. 9850251 - Imidazole derivative used as antiviral agent and use therof in preparation of medicament (2017-12-26),

Title: Innovator Spotlight: Jikui Sun from Shanghai, China

Introduction: Jikui Sun is a distinguished inventor based in Shanghai, China, renowned for his contributions to the field of pharmaceuticals. With a notable portfolio of 8 patents, his innovative work has made significant strides in developing new compounds with promising applications.

Latest Patents: Among his latest inventions, Jikui Sun has developed a class of compounds known as pyrimidoheterocyclic compounds. His recent patents specifically disclose a compound represented by formula (III) or a pharmaceutically acceptable salt thereof. This advancement is anticipated to have a considerable impact on therapeutic applications.

Career Highlights: Throughout his career, Jikui has worked with reputable companies in the pharmaceutical sector, notably Shandong Danhong Pharmaceutical Co., Ltd. and D3 Bio (Wuxi) Co., Ltd. His experience in these organizations has played a crucial role in honing his skills as an innovator.

Collaborations: In the course of his professional journey, Jikui has collaborated with esteemed colleagues such as Shuhui Chen and Jian Li. These partnerships have been instrumental in fostering innovation and advancing research in medicinal chemistry.

Conclusion: Jikui Sun exemplifies the spirit of innovation and dedication to the advancement of pharmaceutical technologies. His groundbreaking work in pyrimidoheterocyclic compounds is a testament to his skills as an inventor, contributing valuable knowledge and potential solutions to pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…